Mammary ductal carcinoma
Mammary ductal carcinoma is a type of breast cancer that originates from the mammary ducts, the tubes that transport milk from the mammary glands to the nipple. It is the most common form of breast cancer, accounting for approximately 80% of all cases.
Etiology[edit | edit source]
The exact cause of mammary ductal carcinoma is unknown, but several risk factors have been identified. These include age, family history of breast cancer, certain genetic mutations such as BRCA1 and BRCA2, and exposure to estrogen over a long period of time.
Pathophysiology[edit | edit source]
Mammary ductal carcinoma begins in the cells lining the mammary ducts. Over time, these cells may mutate and begin to grow uncontrollably, forming a tumor. If left untreated, the cancer can spread to the surrounding breast tissue and to other parts of the body through the lymphatic system or the bloodstream.
Clinical Presentation[edit | edit source]
The most common symptom of mammary ductal carcinoma is a lump in the breast. Other symptoms may include changes in the size or shape of the breast, nipple discharge, and changes in the skin over the breast.
Diagnosis[edit | edit source]
Diagnosis of mammary ductal carcinoma typically involves a combination of physical examination, mammography, ultrasound, and biopsy. The biopsy provides definitive diagnosis by allowing for microscopic examination of the tumor cells.
Treatment[edit | edit source]
Treatment for mammary ductal carcinoma depends on the stage of the disease, the patient's overall health, and personal preferences. Options may include surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy.
Prognosis[edit | edit source]
The prognosis for mammary ductal carcinoma varies widely depending on the stage at diagnosis, the patient's overall health, and the effectiveness of treatment. Early detection and treatment can significantly improve the prognosis.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD